Rafinlar Dabrafenib 50mg Capsule

Get a Price/Quote

MOQ : 10 Pieces

Rafinlar Dabrafenib 50mg Capsule Specification

Dosage Form
Capsule

Packaging Type
Box

Life Span
Refer to expiry date on packaging

Pacakaging (Quantity Per Box)
Not specified (refer to packaging)

Indication
Treatment of unresectable or metastatic melanoma with BRAF V600 mutation

Salt Composition
Dabrafenib 50mg

Brand Name
RAFINLAR

Origin of Medicine
Switzerland

Drug Type
Prescription Only Medicine

Ingredients
Dabrafenib

Physical Form
Capsules

Function
Anti-cancer, targeted therapy

Recommended For
Patients diagnosed with BRAF V600 mutation-positive melanoma

Dosage
As prescribed by physician

Dosage Guidelines
Take orally as directed by healthcare professional

Quantity
Not specified (refer to packaging)

Storage Instructions
Store below 30C, protect from moisture

Contraindications
Patients hypersensitive to Dabrafenib or other components

Mode of Administration
Oral

Prescription Status
Prescription Required

Therapeutic Class
Antineoplastic Agent

Storage Condition
Keep out of reach of children, store in original packaging

Country Availability
Canada, UK, USA, Australia, European Union

Side Effects
Fever, fatigue, rash, headache (not exhaustive, consult leaflet)

Warning
For use under medical supervision only

Rafinlar Dabrafenib 50mg Capsule Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
2-10 Days

Rafinlar Dabrafenib 50mg Capsule About

Experience an enlightened approach to targeted cancer therapy with RAFINLAR Dabrafenib 50mg Capsule. Capitalise on its noteworthy efficacy in the management of unresectable or metastatic melanoma with BRAF V600 mutation. Designed for reduced tumor progression, this classic oral antineoplastic agent is administered under medical supervision, with dosing tailored to your physician's order. Originating from Switzerland and available widely, RAFINLAR offers a prescription-only solution notable for its purity and performance, supporting adults seeking advanced cancer care through reduced side effects and optimal patient outcomes.

Enlightened Usage and Noteworthy Advantages

RAFINLAR Dabrafenib 50mg Capsule, a classic in targeted therapy, is ingeniously formulated for oral usage under medical supervision. Its primary competitive advantages include high specificity for BRAF V600 mutation-positive melanoma, reduced progression rates, and a well-tolerated profile. The site of application being systemic, it addresses malignancies efficiently throughout the body, aligning with physicians' orders for optimal control of advanced skin cancer.

Sample Availability, Domestic Reach, and Supply Chain Efficiency

Samples of RAFINLAR Dabrafenib 50mg Capsule are available for healthcare professionals, with the main domestic market anchored in India and global supply stretching to Canada, the UK, USA, Australia, and the EU. Shipped goods are drop-off ready, with supply ability maintained at a consistent, reliable estimate. Distributors can expect timely deliveries, ensuring ongoing access to this essential anticancer agent for authorized institutions and pharmacies.

FAQ's of Rafinlar Dabrafenib 50mg Capsule:

Q: How should RAFINLAR Dabrafenib 50mg Capsules be taken for optimal effect?

A: RAFINLAR should be taken orally, strictly as prescribed by your healthcare professional. Follow the dosage and timing exactly as directed to capitalise on its benefits.

Q: What conditions is RAFINLAR Dabrafenib primarily indicated for?

A: This medication is indicated for adults with unresectable or metastatic melanoma harboring the BRAF V600 mutation, as confirmed by a medical practitioner.

Q: When is it essential to consult a healthcare provider during RAFINLAR therapy?

A: Consult your healthcare provider immediately if you experience unusual side effects such as persistent fever, severe rash, or fatigue, or before making any changes to your regimen.

Q: Where should RAFINLAR Capsules be stored for maximum safety and efficacy?

A: Store RAFINLAR in its original packaging below 30C, away from moisture, and out of reach of children to ensure safety and stability of the medication.

Q: What are the most noteworthy benefits of using RAFINLAR for melanoma treatment?

A: RAFINLAR offers targeted action against mutations, reduced progression rates, and a favorable safety profile when used under medical supervision, making it a noteworthy option in modern cancer therapy.

Tell us about your requirement